Cuba declares new section of trials for remedy

Cuba declares new section of trials for remedy

Revealed on :

Havana (AFP) – Cuba will start new scientific trials on a drug developed by a nationwide laboratory to deal with Alzheimer’s illness, which is among the many main causes of demise on the island, the well being ministry mentioned in a report on Friday.

“In Cuba, a scientific trial will start within the coming months in all of the provinces of the nation to check the efficacy and security” of the drug NeuroEpo in sufferers with gentle to reasonable Alzheimer’s illness, the Ministry of Well being mentioned. Public Well being on its web site, with out additional particulars on this take a look at section.

The drug, a nasally administered components developed by the Middle for Molecular Immunology (CIM), has proven “good leads to the remedy of neurodegenerative illnesses”, he added.

“In Cuba, dementia is without doubt one of the principal causes of demise and it’s the one which requires probably the most consideration and care within the aged,” the ministry mentioned.

Among the many island’s 11.2 million inhabitants, there are presently 160,000 individuals with dementia, in line with the report.

There have been roughly 46.8 million individuals with dementia worldwide in 2015, a determine that might attain 65 million in 2030. In Latin America and the Caribbean, this determine might rise from 3.4 million to 4.1 million in 2030, in line with figures supplied by the doc.

Cuba is dealing with a fast growing older of its inhabitants, accentuated by the migratory exodus, particularly of younger individuals, who’re fleeing the worst financial disaster of the final 30 years.

In accordance with Cuba’s statistical yearbook, greater than 21% of the island’s inhabitants was over the age of 60 in 2020.

#Cuba #declares #section #trials #remedy

Leave a Comment

Your email address will not be published.

Scroll to Top